A prospective randomised controlled phase III trial of gemcitabine and docetaxel compared with doxorubicin as first line treatment in previously untreated advanced unresectable or metastatic soft tiss...

Mise à jour : Il y a 4 ans
Référence : EUCTR2009-014907-29

A prospective randomised controlled phase III trial of gemcitabine and docetaxel compared with doxorubicin as first line treatment in previously untreated advanced unresectable or metastatic soft tissue sarcomas

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The principal research objective is to compare the efficacy and effectiveness of gemcitabine and docetaxel with that of doxorubicin.


Critère d'inclusion

  • Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma